18793 - Human Photoallergy Test
NCT02750488 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2018-12-13
Summary
To evaluate the potential of a test material to produce a photoallergic response.
Conditions
- Sunscreening Agents
Interventions
- DRUG
-
BAY987517
50 μl/ cm2 of the test article is applied directly to two sites on the skin and covered with the appropriate patch. Twenty-four (24) hours later, the patches are removed. The test sites are lightly wiped with a dry cloth/tissue and 3μl/ cm2 of test article is reapplied directly to the skin of the test site designated for irradiation, and lightly spread over the test site. Forty-eight (48) hours later the procedure is repeated to the same test sites. This process is repeated twice weekly for a total of six exposures.
- OTHER
-
Untreated skin
One site is patched without treatment as control
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-09
- Primary Completion
- 2016-07-01
- Completion
- 2016-07-01
Countries
- United States
Study Locations
More Related Trials
-
Human Photoallergy Test
NCT02751515 ·Status: COMPLETED ·Phase: NA
-
18348-Human Phototoxicity Test
NCT02823483 ·Status: COMPLETED ·Phase: NA
-
To Test for Photo Allergy Reaction of Sunscreens
NCT02872220 ·Status: COMPLETED ·Phase: NA
-
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
NCT02117739 ·Status: COMPLETED ·Phase: PHASE1
-
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
NCT02108483 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT03015103 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1
-
Dermal Photo Allergic Skin Reaction
NCT04070755 ·Status: COMPLETED ·Phase: PHASE1
-
Photopatch Test Study (POST Study)
NCT03812887 ·Status: UNKNOWN
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT02441608 ·Status: COMPLETED ·Phase: NA
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment
NCT00645164 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-Centre European Photopatch Test Study
NCT00530387 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate UV-light-induced Allergic Skin Reactions After Application of Delgocitinib Cream
NCT04807751 ·Status: COMPLETED ·Phase: PHASE1
-
Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results
NCT06872996 ·Status: RECRUITING ·Phase: NA
-
To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects.
NCT07065149 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
NCT00644917 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration
NCT02493283 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects
NCT07109453 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparative Safety Study of New Sinecort Formulation Versus Positive Control
NCT00885937 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB
NCT04853823 ·Status: UNKNOWN ·Phase: PHASE1
-
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
NCT02117752 ·Status: COMPLETED ·Phase: PHASE1
-
Penicillin Allergy Testing and Resensitization Rate
NCT03942731 ·Status: COMPLETED
-
21 Day Cumulative Skin Irritation of RUT058-60
NCT02198963 ·Status: COMPLETED ·Phase: PHASE1
-
Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch
NCT04624867 ·Status: UNKNOWN ·Phase: PHASE1